Ecosystem News
-
Aktiia secures $42 million Series B funding and rebrands to Hilo
In addition to announcing its rebranding to Hilo, Aktiia, a blood pressure intelligence platform, has completed an oversubscribed $42 million Series B funding round, bringing…
startupticker.ch
-
Granite Bio debuts with $100 million to tackle autoimmune diseases
Based in Basel, Granite Bio has emerged from stealth with a focus on developing first-in-class antibodies targeting multiple autoimmune diseases. The company has secured $100…
startupticker.ch
-
Veraxa plans to go public via SPAC at $1.64 billion valuation
Xlife Sciences’ portfolio company VERAXA Biotech AG, a biopharmaceutical company focused on next-generation cancer therapies, and Voyager Acquisition Corp., a special purpose acquisition company listed…
startupticker.ch
-
Cellestia Biotech spins-off Anciata Therapeutics
The newly formed U.S.-based Anciata Therapeutics aims to develop to clinical proof of concept for a first-in-class therapeutic candidate with the potential to treat certain…
startupticker.ch
-
Novigenix obtains EUR 1.8 million EU grant to industrialize AI-powered liquid biopsy
As part of the BRECISE IHI Consortium, Swiss startup Novigenix has been awarded EUR 1.8M funded by the European Union (EU) research initiative focusing on…
startupticker.ch
-
MoonLake Immunotherapeutics secures up to $500 Million in non-dilutive financing
Zug-based MoonLake Immunotherapeutics, a clinical-stage biotechnology company focused on inflammatory diseases, has secured up to $500 million in non-dilutive capital. It provides funding for the…
startupticker.ch
-
Venture Leaders Biotech 2025 cohort revealed
Ten startups have been selected for the 2025 Venture Leaders Biotech program. As part of the Swiss National Startup Team, they will travel to Boston…
startupticker.ch
-
TargImmune Therapeutics gets acquired
iOncologi, a Florida-based clinical-stage company focused on advancing immunotherapy platform technologies, has acquired TargImmune Therapeutics, a Basel-based company specializing in novel tumor targeted immunotherapies. This…
startupticker.ch
-
machineMD secures Topcon Healthcare, Inc. as lead investor for its pre-Series A round
Bern-based machineMD attracted a strategic investment from Topcon Healthcare, Inc., a global leader in robotic diagnostics and digital solutions. Topcon Healthcare has joined machineMD’s pre-Series…
startupticker.ch
-
Taiho Pharmaceutical to acquire Araris Biotech for up to USD 1.1 billion
Japan-based Taiho Pharmaceutical Co., Ltd. and Araris Biotech AG, a Swiss biotechnology company developing next-generation antibody drug conjugates (ADCs), entered into a definitive agreement pursuant…
startupticker.ch
-
Qumea to enhance patient safety in Sweden
After winning the largest European digital mobility monitoring tender to date in Sweden, Solothurn-based Qumea will equip hospitals in the Västra Götaland Region with an…
startupticker.ch
-
Femtech startup Beech Biotech obtains €500K to advance preeclampsia treatment
As part of the BioInnovation Institute (BII) latest Venture Lab program, Lausanne-based Beech Biotech has been awarded €500'000 to further develop a placenta-impermeable antibody to…
startupticker.ch